Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS).
Autores principales: | Taggart, D, Neubauer, S |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2002
|
Ejemplares similares
-
Coronary revascularization--2009: state of the art.
por: Taggart, D
Publicado: (2009) -
Predictors of second revascularization in patients with history of coronary artery bypass graft
por: Gholamreza Davoodi, et al.
Publicado: (2018-01-01) -
Cardiac revascularization: state of the art and perspectives
por: Ambra Cappelletto, et al.
Publicado: (2019-05-01) -
Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1 year outcomes in the Arterial Revascularization Trial (ART)
por: Benedetto, U, et al.
Publicado: (2017) -
Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial)
por: Umberto Benedetto, et al.
Publicado: (2018-03-01)